• Registration ›
• Program ›
• Speakers ›

Research Area	Presenter	Abstract
Agrigenomics	Srinivas Chadaram, PhD Rommel Herrera, DVM Arjun Kandalam, PhD Seokhyun Lee, PhD Ryoma Takeshima, PhD	Molecular breeding can significantly reduce the cost and time required to deliver improved plant and animal species for agricultural use. Advancements in genomic technologies are accelerating these breeding programs by enabling higher-throughput genotyping across large populations than ever before. Hear from crop and livestock breeding scientists from the Asia-Pacific-Japan region and Thermo Fisher Scientiic’s experts about how they have utilized Thermo Fisher Scientific’s genotyping solutions to achieve accurate marker-assisted breeding selection, improve livestock parentage discrimination and trait monitoring. Some of these applications range from elucidating the characteristics and genetically improving the agricultural traits of buckwheat to increasing the genomic accuracy for dairy cattle in S. Korea.
Applied Genomics - Microbiome Research	Kamlesh Jangid, PhD Keun-Joon Park, PhD	Microbiome research and its impact on health continues to grow rapidly as genomic microbial databases grow and further insights are gleaned from basic research and clinical investigations. Its well-known and widely published that a healthy microbiota improves host response against a pathogen.  Access this session to understand  about CE and different NGS methods that can empower your microbiome research.
Applied Genomics - QC in Genomics	Steve Jackson, PhD Harita Veereshlingam, PhD Emily Zeringer, PhD	Confirming and validating of what have discovered in genomic level on the way of accomplishing the research project is very critical. Here we are presenting 2 topics to help you make sure your research is going in right direction. The first topic is about cell line authentication which is to verify a line’s identity and to show its free of contamination from other cell lines and microbes, and another topic is how to normalize the miRNA expression variability.
Applied Genomics - Reproductive Health	Ashwin Dalal, MD Ritu Hari, PhD Youngjoo Jeon, PhD Mohamed Saleem, PhD Anuradha Udumudi, PhD	In this section you will hear from key opinion leaders in reproductive health research about how new molecular technologies are providing more accurate results, both faster and more cost-effectively than was previously possible. From expanded carrier screening, through preimplantation genetic testing (PGT-A and PGT-M) analysis in IVF research, to pre- and postnatal applications, this series will spotlight how advanced molecular technologies from Thermo Fisher Scientific are enabling researchers worldwide to achieve their goals and positively impact families as a result.
SARS-CoV-2 Research	Soren Alexandersen, PhD Rachel Formosa, PhD Anjali Shah, PhD Timothy Triche, MD, PhD	As we know researchers around the world are diligently working to gain a better understanding of the novel coronavirus with the goal of rapidly identifying future treatment options and possible vaccine targets. With a comprehensive portfolio of genetic anaylsis products, Thermo Fisher Scientific is your trusted partner for virus discovery, pathogen detection, epidemiological surveillance, vaccine development, and host genetics to advance your research. Hear from us and your peers on the emerging applications for SARS-CoV-2 research with specific case studies examples.
Translational Genomics - Clinical Oncology Research	Charles Baudo, PhD Yosuke Hirotsu, PhD Michael Hummel, PhD Sudha Murthy, MD Jon Sherlock, PhD	Even in these difficult times, research, learning, and knowledge exchange in precision oncology research must continue, just as routine patient testing and treatment must. Whether your laboratory currently utilizes next-generation sequencing (NGS) or Capillary Electrophoresis (CE) , or you are curious to learn more, access this Session to hear about the latest developments in cancer genomic profiling—from research to diagnostics.
Translational Genomics - Precision medicine	Shantanu Kaushikkar, MS, MBA Kyung-Won Hong, PhD Richard Pither, PhD	Precision medicine can be enabled via predictive genomics – a powerful capability to help predict disease risk, understand drug response and thus manage healthcare costs. Large population scale predictive genomic studies implemented on the Applied Biosystems Axiom Microarray platform have led to personalized health outcomes. These include the prestigious UK Biobank and the Finngen projects in which genotyping data from customized Axiom microarrays were integrated with biobank data and electronic health records to create a national precision medicine asset of lasting value. Likewise, Polygenic Risk Scores (PRS) are gaining traction for identifying individual genetic risk and disease risk prediction. Hear from scientists around the world and Thermo Fisher Scientific experts on how such population scale genotyping projects and translational research studies have been implemented using the Axiom platform to help predict disease risk, develop PRS scores for Alzheimer’s and commercialize a genetic testing service for an Asian population.